Chinese English Germany Japanese

ShangHai Biochempartner Co.,Ltd회사는 제품 목록을 제공합니다.

회사 명:ShangHai Biochempartner Co.,Ltd
전화:177-54423994
이메일:2853530910@QQ.com
국적:China
URL: www.biochempartner.com
총 제품 수:8000
63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80

제품 카탈로그

(2-fluoro-3-methoxy-6-(1H-tetrazol-1-yl)phenyl)methanamine1821248-00-3C9H10FN5O
NE10790152831-36-2C8H10NO6P
FLT3-IN-32229050-90-0C27H38N8O
WAY-181187 hydrochloride554403-08-6C15H14Cl2N4O2S2
4-[2-(2,6-dioxo-3-piperidinyl)-6-fluoro-2,3-dihydro-1,3-dioxo-1Hisoindol-5-yl]-, 1,1-dimethylethyl ester-1-Piperazinecarboxylic acid2222116-02-9C22H25FN4O6
PBD dimer1222490-34-7C42H39N5O7
Phentolamine Analogue 147142-51-8C17H19N3O
Apixaban Impurity 381802522-36-6C10H16Cl2O3
TY-52156타이-52156934369-14-9C18H19Cl2N3O
6-Cyclopropyl-1-isopropyl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid851288-57-8C13H15N3O2
Ebastine Impurity G1429071-65-7C32H39NO3
Budesonide Impurity 73949-79-9C23H28O7
UNC69342561494-77-5C24H21N5O4
Ebastine Impurity F1429071-63-5C32H39NO3
TBI-1661353734-12-9C32H30F3N5O3
Daunomycinone21794-55-8C21H18O8
CR8, (R)-Isomer294646-77-8C24H29N7O
FIDAS-31266684-01-8C16H15F2N
BMS-9861761815613-42-3C19H23F4N3O
(R)-CR8 trihydrochloride1786438-30-9C24H30ClN7O
SJ-172550431979-47-4C22H21ClN2O5
Ibalizumab680188-33-4
Otelixizumab881191-44-2
Tigatuzumab918127-53-4
Panobacumab885053-97-4
NVR-3-7781445790-55-5C18H16F4N2O4S
I-BET5671887237-54-8C17H18ClN5O2
Raxibacumab락시바쿠맙565451-13-0
Tefibazumab테피바주맙521079-87-8
Yttrium (90Y) Tacatuzumab Tetraxetan476413-07-7
Bapineuzumab바피누주맙648895-38-9
Pagibaximab파기박시맙595566-61-3
Sontuzumab손투주맙372075-37-1
Iratumumab640735-09-7
Disitamab Vedotin2136633-23-1
Edrecolomab에드레콜로맙156586-89-9
Libivirumab569658-79-3
7-O-(Triethylsilyl) Baccatin III7-O-(트리에틸실릴)바카틴III115437-21-3C37H52O11Si
GSK 20331221277-90-2C29H28F3NO5S2
Besilesomab베실레소맙537694-98-7
Volociximab볼로식시맙558480-40-3
BVT94839674-97-0C14H11NO3
HLY78854847-61-3C17H17NO2
Exbivirumab569658-80-6
elsilimomab엘실리모맙468715-71-1
Oxelumab1186098-83-8
Rilotumumab872514-65-3
SIS3Smad3억제제,SIS31009104-85-1C28H27N3O3
YH531471484-62-4C30H33N5O5S
RGD Trifluoroacetate2378808-45-6C14H23F3N6O8
EIT hydrobromide1071-37-0C3H9BrN2S
Robatumumab934235-44-6
Teneliximab아셀리주맙395639-53-9
Pritumumab프리투무맙499212-74-7
Elotuzumab915296-00-3
Anatumomab
Vapaliximab336801-86-6
Reslizumab241473-69-8
Ecromeximab292819-64-8
Erlizumab루맙CD168211323-03-4
Figitumumab943453-46-1
Farletuzuma896723-44-7
Cixutumumab947687-12-9
Lemalesomab250242-54-7
Sibrotuzumab216669-97-5
Bivatuzumab
Olokizumab1007223-17-7
Foralumab946415-64-1
Drozitumab912628-39-8
Itolizumab1116433-11-4
Ensituximab1092658-06-4
Teprotumumab1036734-93-6
Glembatumumab1020264-78-1
Lebrikizumab953400-68-5
Fezakinumab1007106-86-6
Suvizumab914257-21-9
Girentuximab916138-87-9
Rontalizumab948570-30-7
Dalotuzumab1005389-60-5
Mavrilimumab1085337-57-0
Sifalimumab1006877-41-3
Intetumumab725735-28-4
Maslimomab127757-92-0
Altumomab156586-92-4
Vepalimomab195158-85-1
Nerelimomab162774-06-3
Minretumomab195189-17-4
Bectumomab벡투모맙158318-63-9
Morolimumab
Rovelizumab339086-79-2
Mogamulizumab1159266-37-1
Faralimomab파라리모맙167816-91-3
Icrucumab1024603-92-6
Fulranumab902141-80-4
Atinumab1226761-65-4
Carlumab915404-94-3
Samalizumab1073059-33-2
Enavatuzumab1062149-33-0
Etrolizumab1044758-60-2
Enokizumab909875-08-7
63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80
Copyright 2019 © ChemicalBook. All rights reserved